-
1
-
-
79958206937
-
Sirtuins, aging, and medicine
-
Guarente L: Sirtuins, aging, and medicine. N Engl J Med 364:2235-2244, 2011.
-
(2011)
N Engl J Med
, vol.364
, pp. 2235-2244
-
-
Guarente, L.1
-
3
-
-
77949887506
-
Mammalian sirtuins: Biological insights and disease relevance
-
Hagis MC, Sinclair DA: Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 5:253-295, 2010.
-
(2010)
Annu Rev Pathol
, vol.5
, pp. 253-295
-
-
Hagis, M.C.1
Sinclair, D.A.2
-
4
-
-
77953287165
-
Mitochondrial sirtuins
-
Huang JY, Hirschey MD, Shimazu T, Ho L, Verdin E: Mitochondrial sirtuins. Biochim Biophys Acta 1804(8):1645-1665, 2010.
-
(2010)
Biochim Biophys Acta
, vol.1804
, Issue.8
, pp. 1645-1665
-
-
Huang, J.Y.1
Hirschey, M.D.2
Shimazu, T.3
Ho, L.4
Verdin, E.5
-
5
-
-
84870880080
-
Proteomic investigations of lysine acetylation identify diverse substrates of mitochondrial deacetylase sirt3
-
Sol EM, Wagner SA, Weinert BT, Kumar A, Kim HS, Deng CX, Choudhary C: Proteomic investigations of lysine acetylation identify diverse substrates of mitochondrial deacetylase sirt3. PLoS One 7(12):e50545, 2012.
-
(2012)
PLoS One
, vol.7
, Issue.12
-
-
Sol, E.M.1
Wagner, S.A.2
Weinert, B.T.3
Kumar, A.4
Kim, H.S.5
Deng, C.X.6
Choudhary, C.7
-
6
-
-
84867186480
-
Quantitative acetylome analysis reveals the roles of SIRT1 in regulating diverse substrates and cellular pathways
-
Chen Y, Zhao W, Yang JS, Cheng Z, Luo H, Lu Z, Tan M, Gu W, Zhao Y: Quantitative acetylome analysis reveals the roles of SIRT1 in regulating diverse substrates and cellular pathways. Mol Cell Proteomics Oct 11(10):1048-1062, 2012.
-
(2012)
Mol Cell Proteomics Oct
, vol.11
, Issue.10
, pp. 1048-1062
-
-
Chen, Y.1
Zhao, W.2
Yang, J.S.3
Cheng, Z.4
Luo, H.5
Lu, Z.6
Tan, M.7
Gu, W.8
Zhao, Y.9
-
7
-
-
63549094179
-
Small molecule activators of SIRT1 replicate signaling pathways triggered by caloric restriction in vivo
-
Smith JJ, Kenney RD, Gagne DJ, Frushour BP, Ladd W, Galonek HL, Israelian K, Song J, Razvadauskaite G, Lynch AV, et al.: Small molecule activators of SIRT1 replicate signaling pathways triggered by caloric restriction in vivo. BMJ Syst Biol 3:331, 2009.
-
(2009)
BMJ Syst Biol
, vol.3
, pp. 331
-
-
Smith, J.J.1
Kenney, R.D.2
Gagne, D.J.3
Frushour, B.P.4
Ladd, W.5
Galonek, H.L.6
Israelian, K.7
Song, J.8
Razvadauskaite, G.9
Lynch, A.V.10
-
8
-
-
33745203038
-
The biochemistry of sirtuins
-
Sauve AA,Wolberger C, Schramm VL, Boeke JD: The biochemistry of sirtuins. Annu Rev Biochem 75:435-465, 2006.
-
(2006)
Annu Rev Biochem
, vol.75
, pp. 435-465
-
-
Sauve, A.A.1
Wolberger, C.2
Schramm, V.L.3
Boeke, J.D.4
-
9
-
-
84871143981
-
Minireview Series on Sirtuins: From biochemistry to health and disease
-
Denu JM, Gottesfeld JM: Minireview Series on Sirtuins: from biochemistry to health and disease. J Biol Chem 287(51):42417-42418, 2012.
-
(2012)
J Biol Chem
, vol.287
, Issue.51
, pp. 42417-42418
-
-
Denu, J.M.1
Gottesfeld, J.M.2
-
10
-
-
0034677535
-
Transcriptional silencing and longevity protein SIRT1 is NAD-dependent histone deacetylase
-
Imai S, Armstrong CM, Kaeberlein M, Guarente L: Transcriptional silencing and longevity protein SIRT1 is NAD-dependent histone deacetylase. Nature 403:795-800, 2000.
-
(2000)
Nature
, vol.403
, pp. 795-800
-
-
Imai, S.1
Armstrong, C.M.2
Kaeberlein, M.3
Guarente, L.4
-
11
-
-
14544282413
-
Nutrient control of glucose homeostasis through a complex of PGC-1a in SIRT-1
-
Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P: Nutrient control of glucose homeostasis through a complex of PGC-1a in SIRT-1. Nature 434:113-118, 2005.
-
(2005)
Nature
, vol.434
, pp. 113-118
-
-
Rodgers, J.T.1
Lerin, C.2
Haas, W.3
Gygi, S.P.4
Spiegelman, B.M.5
Puigserver, P.6
-
12
-
-
1342264308
-
Mammalian SIRT1 represses forkhead transcription factors
-
Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W, Bultsma Y, McBurney M, Guerente L: Mammalian SIRT1 represses forkhead transcription factors. Cell 116:551-553, 2004.
-
(2004)
Cell
, vol.116
, pp. 551-553
-
-
Motta, M.C.1
Divecha, N.2
Lemieux, M.3
Kamel, C.4
Chen, D.5
Gu, W.6
Bultsma, Y.7
McBurney, M.8
Guerente, L.9
-
13
-
-
3242719545
-
Modulation of NF-kB-dependent transcription and cell survival by the SIRT1 deacetylase
-
Yeung F, Holberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW: Modulation of NF-kB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23:2369-2380, 2004.
-
(2004)
EMBO J
, vol.23
, pp. 2369-2380
-
-
Yeung, F.1
Holberg, J.E.2
Ramsey, C.S.3
Keller, M.D.4
Jones, D.R.5
Frye, R.A.6
Mayo, M.W.7
-
14
-
-
38649132337
-
Mitochondria: A nexus of aging caloric restriction and sirtuins?
-
Guarente L: Mitochondria: a nexus of aging caloric restriction and sirtuins? Cell 132:171-176, 2008.
-
(2008)
Cell
, vol.132
, pp. 171-176
-
-
Guarente, L.1
-
15
-
-
77958488312
-
SIRT1 activation by small molecules: Kinetic and biophysical evidence for direct interaction of enzyme and activator
-
Dai H, Kustigian L, Carney D, Case A, Considine T, Hubbard BP, Perni RB, Riera TV, Szczepankiewicz B, Vlasuk GP, et al.: SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator. J Biol Chem 285:32695-32703, 2010.
-
(2010)
J Biol Chem
, vol.285
, pp. 32695-32703
-
-
Dai, H.1
Kustigian, L.2
Carney, D.3
Case, A.4
Considine, T.5
Hubbard, B.P.6
Perni, R.B.7
Riera, T.V.8
Szczepankiewicz, B.9
Vlasuk, G.P.10
-
16
-
-
84874721105
-
Evidence for a common mechanism of SIRT1 regulation by allosteric activators
-
Hubbard BP, Gomes AP, Dai H, Li J, Case AW, Considine T, Riera TV, Lee JE, E SY, Lamming DW, et al.: Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science 339(6124):1216-1219, 2013.
-
(2013)
Science
, vol.339
, Issue.6124
, pp. 1216-1219
-
-
Hubbard, B.P.1
Gomes, A.P.2
Dai, H.3
Li, J.4
Case, A.W.5
Considine, T.6
Riera, T.V.7
Lee, J.E.8
Lamming, D.W.9
-
17
-
-
33745962138
-
Therapeutic potential of resveratrol: The in vivo evidence
-
Baur JA, Sinclair DA: Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493-506, 2006.
-
(2006)
Nat Rev Drug Discov
, vol.5
, pp. 493-506
-
-
Baur, J.A.1
Sinclair, D.A.2
-
18
-
-
84887936276
-
The identification of the SIRT1 activator SRT 2014 as a clinical candidate
-
Ng PY, Bemis JE, Disch JS, Vu CB, Oalmann CJ, Lynch AV: The identification of the SIRT1 activator SRT 2014 as a clinical candidate. Lett Drug Design Discov 10:793-797, 2013.
-
(2013)
Lett Drug Design Discov
, vol.10
, pp. 793-797
-
-
Ng, P.Y.1
Bemis, J.E.2
Disch, J.S.3
Vu, C.B.4
Oalmann, C.J.5
Lynch, A.V.6
-
19
-
-
84924866970
-
SRT2104 extends survival of male mice on a standard diet and preserves bone and muscle mass
-
Mercken EM, Mitchell SJ, Martin-Montalvo A, Minor RK, Almeida M, Gomes AP, Scheibye-Knudsen M, Palacios HH, Licata JJ, Zhang Y, et al.: SRT2104 extends survival of male mice on a standard diet and preserves bone and muscle mass. Aging Cell 13:787-796, 2014.
-
(2014)
Aging Cell
, vol.13
, pp. 787-796
-
-
Mercken, E.M.1
Mitchell, S.J.2
Martin-Montalvo, A.3
Minor, R.K.4
Almeida, M.5
Gomes, A.P.6
Scheibye-Knudsen, M.7
Palacios, H.H.8
Licata, J.J.9
Zhang, Y.10
-
20
-
-
84961948701
-
12 weeks of treatment with an oral SIRT1 activator, SRT2104, leads to clinical improvement and skin microarray modification in patients with psoriasis
-
JacobsonEW, Suárez-Farinãs M, Cueto I, Katcherian A, Matheson R, Parish LC, Shortino D, Gupta A, Vlasuk GP, Krueger JG: 12 weeks of treatment with an oral SIRT1 activator, SRT2104, leads to clinical improvement and skin microarray modification in patients with psoriasis. J Invest Derm 133:S159-S190, 2013.
-
(2013)
J Invest Derm
, vol.133
, pp. S159-S190
-
-
Jacobson, E.W.1
Suárez-Farinãs, M.2
Cueto, I.3
Katcherian, A.4
Matheson, R.5
Parish, L.C.6
Shortino, D.7
Gupta, A.8
Vlasuk, G.P.9
Krueger, J.G.10
-
21
-
-
84871431259
-
A pilot randomized, placebo controlled, double blind phase i trial of the novel SIRT1 activator SRT2104 in elderly volunteers
-
Libri V, Brown AP, Gambarota G, Haddad J, Shields GS, Dawes H, Pinato DJ, Hoffman E, Elliot PJ, Vlasuk GP, et al.: A pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers. PLoS One 7(12):e15395, 2012.
-
(2012)
PLoS One
, vol.7
, Issue.12
-
-
Libri, V.1
Brown, A.P.2
Gambarota, G.3
Haddad, J.4
Shields, G.S.5
Dawes, H.6
Pinato, D.J.7
Hoffman, E.8
Elliot, P.J.9
Vlasuk, G.P.10
-
22
-
-
84907059211
-
The sirtuin1 activator SRT3025 down-regulates sclerostin and rescues ovariectomy-induced bone loss and biomechanical deterioration in female mice
-
Artsi H, Cohen-Kfir E, Gurt I, Shahar R, Bajayo A, Kalish N, Bellido TM, Gabet Y, Dresner-Pollak R: The sirtuin1 activator SRT3025 down-regulates sclerostin and rescues ovariectomy-induced bone loss and biomechanical deterioration in female mice. Endocrinology 155:3208-3515, 2014.
-
(2014)
Endocrinology
, vol.155
, pp. 3208-3515
-
-
Artsi, H.1
Cohen-Kfir, E.2
Gurt, I.3
Shahar, R.4
Bajayo, A.5
Kalish, N.6
Bellido, T.M.7
Gabet, Y.8
Dresner-Pollak, R.9
-
23
-
-
84961291948
-
The SIRT1 activator SRT3025 provides atheroprotection in Apoe-/-mice by reducing hepatic PCSK9 secretion and enhancing Ldlr expression
-
Miranda MX, van Tits LJ, Lohmann C, Arsiwala T, Winnik S, Talleux A, Stein S, Gomes AP, Suri V, Ellis JL, et al.: The SIRT1 activator SRT3025 provides atheroprotection in Apoe-/-mice by reducing hepatic PCSK9 secretion and enhancing Ldlr expression. Euro Heart J 36:51-59, 2015.
-
(2015)
Euro Heart J
, vol.36
, pp. 51-59
-
-
Miranda, M.X.1
Van Tits, L.J.2
Lohmann, C.3
Arsiwala, T.4
Winnik, S.5
Talleux, A.6
Stein, S.7
Gomes, A.P.8
Suri, V.9
Ellis, J.L.10
-
24
-
-
85041813459
-
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
-
Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG: Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 8(6):e1000412, 2010.
-
(2010)
PLoS Biol
, vol.8
, Issue.6
-
-
Kilkenny, C.1
Browne, W.J.2
Cuthill, I.C.3
Emerson, M.4
Altman, D.G.5
-
25
-
-
84860477354
-
SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function
-
Price NL, Gomes AP, Ling AJY, Duarte FU, Martin-Montalvo A, North B, Agarwal B, Ye L, Ramadori G, Teodoro JS, et al.: SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 15:675-690, 2012.
-
(2012)
Cell Metab
, vol.15
, pp. 675-690
-
-
Price, N.L.1
Gomes, A.P.2
Ling, A.J.Y.3
Duarte, F.U.4
Martin-Montalvo, A.5
North, B.6
Agarwal, B.7
Ye, L.8
Ramadori, G.9
Teodoro, J.S.10
-
26
-
-
33646759609
-
Cecal ligation and puncture
-
Hubbard WJ, Choudhry MA, Schwacha MG, Kerby JD, Rue LW, Bland KI, Chaudry IH: Cecal ligation and puncture. Shock 24(Suppl 1):52-57, 2005.
-
(2005)
Shock
, vol.24
, pp. 52-57
-
-
Hubbard, W.J.1
Choudhry, M.A.2
Schwacha, M.G.3
Kerby, J.D.4
Rue, L.W.5
Bland, K.I.6
Chaudry, I.H.7
-
27
-
-
28744458859
-
Bioconductor: Open software development for computational biology and bioinformatics
-
Gentleman RC, Carey VJ, Bates DM, Bolstad B, DettlingM, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al.: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5(10):R80, 2004.
-
(2004)
Genome Biol
, vol.5
, Issue.10
, pp. R80
-
-
Gentleman, R.C.1
Carey, V.J.2
Bates, D.M.3
Bolstad, B.4
Dettling, M.5
Dudoit, S.6
Ellis, B.7
Gautier, L.8
Ge, Y.9
Gentry, J.10
-
28
-
-
4544341015
-
Linear models and empirical Bayes methods for assessing differential expression in microarray experiments
-
Article 3
-
Smyth GK: Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3. Article 3.
-
Stat Appl Genet Mol Biol
, vol.3
-
-
Smyth, G.K.1
-
29
-
-
84961945798
-
Controlling the false discovery rate: A practical and powerful approach to multiple testing
-
Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc Series B 57:289-300, 1995.
-
(1995)
J R Statist Soc Series B
, vol.57
, pp. 289-300
-
-
Benjamini, Y.1
Hochberg, Y.2
-
30
-
-
84906050253
-
SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome
-
Vachharajani VT, Liu TF, Brown CM, Wang X, Buechler NL, Wells JD, Yoza BK, McCall CE: SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome. J Leuk Bio 96(5):785-796, 2014.
-
(2014)
J Leuk Bio
, vol.96
, Issue.5
, pp. 785-796
-
-
Vachharajani, V.T.1
Liu, T.F.2
Brown, C.M.3
Wang, X.4
Buechler, N.L.5
Wells, J.D.6
Yoza, B.K.7
McCall, C.E.8
-
31
-
-
84927722620
-
Sirt1 restrains lung inflammasome activation in a murine model of sepsis
-
Gao R, Ma Z, Hu Y, Chen J, Shetty S, Fu J: Sirt1 restrains lung inflammasome activation in a murine model of sepsis. Am J Physio Lung Mol Physio 308(8):L847-L853, 2015.
-
(2015)
Am J Physio Lung Mol Physio
, vol.308
, Issue.8
, pp. L847-L853
-
-
Gao, R.1
Ma, Z.2
Hu, Y.3
Chen, J.4
Shetty, S.5
Fu, J.6
-
32
-
-
84944345297
-
Sirtuin 1 activator SRT1720 protects against organ injury induced by intestinal ischemia-reperfusion
-
Hansen LW, Khader A, Yang WL, Prince JM, Nicastro JM, Coppa GF, Wang P: Sirtuin 1 activator SRT1720 protects against organ injury induced by intestinal ischemia-reperfusion. Shock 45(4):359-366, 2016.
-
(2016)
Shock
, vol.45
, Issue.4
, pp. 359-366
-
-
Hansen, L.W.1
Khader, A.2
Yang, W.L.3
Prince, J.M.4
Nicastro, J.M.5
Coppa, G.F.6
Wang, P.7
-
33
-
-
84905741001
-
Interferon beta protects against lethal endotoxic and septic shock through SITR1 upregulation
-
Yoo C-H, Yeom J-H, Heo J-J, Song E-K, Lee S-I, Han M-K: Interferon beta protects against lethal endotoxic and septic shock through SITR1 upregulation. Sci Rep 4:4220, 2014.
-
(2014)
Sci Rep
, vol.4
, pp. 4220
-
-
Yoo, C.-H.1
Yeom, J.-H.2
Heo, J.-J.3
Song, E.-K.4
Lee, S.-I.5
Han, M.-K.6
-
34
-
-
70350498834
-
The molecular pathogenesis of pneumococcal pneumonia
-
Van der Poll T, Opal SM: The molecular pathogenesis of pneumococcal pneumonia. Lancet 374:1543-1556, 2009.
-
(2009)
Lancet
, vol.374
, pp. 1543-1556
-
-
Van Der Poll, T.1
Opal, S.M.2
|